| Entry |
|
|---|
| Name |
Halobetasol propionate (USP);
Ulobetasol propionate;
Ultravate (TN) |
|---|
| Product |
|
|---|
| Generic |
HALOBETASOL PROPIONATE (Bryant Ranch Prepack), HALOBETASOL PROPIONATE (Bryant Ranch Prepack), HALOBETASOL PROPIONATE (Bryant Ranch Prepack), HALOBETASOL PROPIONATE (Bryant Ranch Prepack), HALOBETASOL PROPIONATE (Bryant Ranch Prepack), HALOBETASOL PROPIONATE (Bryant Ranch Prepack), HALOBETASOL PROPIONATE (Cosette Pharmaceuticals), HALOBETASOL PROPIONATE (Cosette Pharmaceuticals), HALOBETASOL PROPIONATE (Fougera Pharmaceuticals), HALOBETASOL PROPIONATE (Mayne Pharma), HALOBETASOL PROPIONATE (Padagis Israel Pharmaceuticals), HALOBETASOL PROPIONATE (Padagis Israel Pharmaceuticals), HALOBETASOL PROPIONATE (QUAGEN PHARMACEUTICALS LLC), HALOBETASOL PROPIONATE (Taro Pharmaceuticals U.S.A.), HALOBETASOL PROPIONATE (Taro Pharmaceuticals U.S.A.) |
|---|
| Formula |
C25H31ClF2O5
|
|---|
| Exact mass |
484.1828
|
|---|
| Mol weight |
484.9604
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
|
|---|
| Remark |
| Product (DG00421): | D04409<US> |
| Product (mixture): | D11932<US> |
|
|---|
| Efficacy |
Anti-inflammatory, Glucocorticoid receptor agonist |
|---|
| Disease |
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D07A CORTICOSTEROIDS, PLAIN
D07AC Corticosteroids, potent (group III)
D07AC21 Ulobetasol
D04409 Halobetasol propionate (USP) <US>
USP drug classification [BR:br08302]
Dermatological Agents
Dermatitis and Pruitus Agents
Glucocorticoids, Very High Potency
Halobetasol
D04409 Halobetasol propionate (USP)
Drug groups [BR:br08330]
Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid
DG00421 Halobetasol
D04409 Halobetasol propionate
Drug classes [BR:br08332]
Anti-inflammatory
DG01955 Corticosteroid
D04409 Halobetasol propionate
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C1 (GR)
D04409 Halobetasol propionate (USP) <US>
Topical steroids potency [br08317.html]
Classification in the USA
D04409
Drug groups [BR:br08330]
Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid
DG00421 Halobetasol
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 33
1 C2x C 15.2600 -25.4100
2 C5x C 15.2600 -26.8100
3 C2x C 16.4500 -27.5100
4 C2y C 17.7100 -26.8100
5 C1z C 17.7100 -25.4100
6 C2x C 16.4500 -24.7100
7 C1y C 18.9000 -27.5100
8 C1x C 20.0900 -26.8100
9 C1y C 20.0900 -25.4100
10 C1z C 18.9000 -24.7100
11 C1y C 21.3500 -24.7100
12 C1z C 21.3500 -23.3100
13 C1x C 20.0900 -22.6100
14 C1y C 18.9000 -23.3100
15 C1x C 23.7300 -24.7100
16 C1y C 23.7300 -23.3100
17 C1z C 22.5400 -22.6100
18 O5x O 14.0700 -27.5100
19 C1a C 17.7100 -24.0100
20 X F 18.9000 -26.1100
21 X F 18.9000 -28.9100
22 O1a O 17.7100 -22.6100
23 C1a C 21.3500 -21.9100
24 O7a O 23.7300 -21.9100
25 C7a C 25.1300 -21.9100
26 O6a O 25.8300 -20.6975
27 C1b C 25.8300 -23.1224
28 C1a C 27.2298 -23.1224
29 C5a C 22.5400 -20.9300
30 O5a O 23.7524 -20.2300
31 C1b C 21.3276 -20.2300
32 X Cl 20.1321 -20.9204
33 C1a C 25.1417 -23.1902
BOND 36
1 1 2 1
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 1
6 1 6 2
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 5 10 1
12 9 11 1
13 11 12 1
14 12 13 1
15 13 14 1
16 10 14 1
17 11 15 1
18 15 16 1
19 16 17 1
20 12 17 1
21 2 18 2
22 5 19 1 #Up
23 10 20 1 #Down
24 7 21 1 #Down
25 14 22 1 #Up
26 12 23 1 #Up
27 17 24 1 #Down
28 24 25 1
29 25 26 2
30 25 27 1
31 27 28 1
32 17 29 1 #Up
33 29 30 2
34 29 31 1
35 31 32 1
36 16 33 1 #Up
|
|---|
